Sun Pharmaceutical Industries Profit & Loss Annual

Trade
BSE: 524715 | NSE: SUNPHARMA | ISIN: INE044A01036 | Sector: Biotechnology & Drugs
1,887.40 -43.80 (-2.27%)Updated : 10 Oct 2024
Fiscal Period2024202320222021
Period End DateMar 24Mar 23Mar 22Mar 21
Revenue 48,496.8543,885.6838,654.4933,498.14
Total Revenue 48,496.8543,885.6838,654.4933,498.14
Costof Revenue Total 10,662.6111,942.4211,707.659,885.42
Gross Profit 37,834.2431,943.2626,946.8423,612.72
Selling/ General/ Admin Expenses Total 9,429.0619,394.8715,945.4214,344.76
Depreciation/ Amortization 2,556.642,529.432,143.742,079.95
Unusual Expense( Income) 494.32188.374,570.274,307.00
Other Operating Expenses Total 15,418.18738.24709.74734.39
Total Operating Expense 38,560.8134,793.3335,076.8231,351.52
Operating Income 9,936.049,092.353,577.672,146.62
Interest Inc( Exp) Net- Non- Op Total -2,023.402,812.305,347.305,862.80
Other Net 1,354.1927.31334.1752.59
Net Income Before Taxes 11,087.899,408.434,481.322,799.37
Provisionfor Income Taxes 1,439.45847.591,075.50514.69
Net Income After Taxes 9,648.448,560.843,405.822,284.68
Minority Interest -33.65-39.36-116.55631.47
Equity In Affiliates -384.10-479.00-165.40-123.30
Net Income Before Extra Items 9,576.388,473.583,272.732,903.82
Net Income 9,576.388,473.583,272.732,903.82
Income Availableto Com Excl Extra Ord 9,576.388,473.583,272.732,903.82
Income Availableto Com Incl Extra Ord 9,576.388,473.583,272.732,903.82
Diluted Net Income 9,576.388,473.583,272.732,903.82
Diluted Weighted Average Shares 240.01239.93239.93239.93
Diluted EPS Excluding Extra Ord Items 39.9035.3213.6412.10
DPS- Common Stock Primary Issue 13.5011.5010.007.50
Diluted Normalized EPS 41.6936.0128.0326.71
Gain( Loss)on Saleof Assets -75.40347.50138.80
*All figures in crores except per share values
Recommended For You
Trending Stocks
1,875.65+74.95(4.16%)
1,662.30+28.60(1.75%)
1,360.50+19.20(1.43%)
1,620.30-38.40 (-2.32%)
HomeMarketsPremiumInstant LoanMint Shorts